Accumulating evidence demonstrated the role of PD-L1 expression in patients’ survival and treatment response [6, 10, 27–31] but the role of PD-L1 / PD-1 in cancer initiation or recurrence is not known yet. This evidence concerns the gene CD274 and cancer.